Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 54

1.

Four-year follow-up of inflammatory arthropathy patients treated with golimumab: Data from the observational multicentre NOR-DMARD study.

Michelsen B, Sexton J, Wierød A, Bakland G, Rødevand E, Krøll F, Kvien TK.

Semin Arthritis Rheum. 2020 Feb;50(1):12-16. doi: 10.1016/j.semarthrit.2019.07.003. Epub 2019 Jul 12.

PMID:
31358361
2.

Predicting achievement of the treatment targets at 6 months from 3-month response levels in rheumatoid arthritis: data from real-life follow-up in the NOR-DMARD study.

Norvang V, Sexton J, Kristianslund EK, Olsen IC, Uhlig T, Bakland G, Krøll F, Rødevand E, Wierød A, Kvien TK, Smolen JS, Aletaha D, Haavardsholm EA.

RMD Open. 2018 Oct 26;4(2):e000773. doi: 10.1136/rmdopen-2018-000773. eCollection 2018.

3.

Treat to target strategy in early rheumatoid arthritis versus routine care - A comparative clinical practice study.

Brinkmann GH, Norvang V, Norli ES, Grøvle L, Haugen AJ, Lexberg ÅS, Rødevand E, Bakland G, Nygaard H, Krøll F, Widding-Hansen IJ, Bjørneboe O, Thunem C, Kvien T, Mjaavatten MD, Lie E.

Semin Arthritis Rheum. 2019 Apr;48(5):808-814. doi: 10.1016/j.semarthrit.2018.07.004. Epub 2018 Jul 25.

PMID:
30205983
4.

Health-related quality of life in patients with psoriatic and rheumatoid arthritis: data from the prospective multicentre NOR-DMARD study compared with Norwegian general population controls.

Michelsen B, Uhlig T, Sexton J, van der Heijde D, Hammer HB, Kristianslund EK, Wierød A, Bakland G, Rødevand E, Krøll F, Loge JH, Haugeberg G, Kvien TK.

Ann Rheum Dis. 2018 Sep;77(9):1290-1294. doi: 10.1136/annrheumdis-2018-213286. Epub 2018 Jun 6.

PMID:
29875096
5.

Do depression and anxiety reduce the likelihood of remission in rheumatoid arthritis and psoriatic arthritis? Data from the prospective multicentre NOR-DMARD study.

Michelsen B, Kristianslund EK, Sexton J, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK.

Ann Rheum Dis. 2017 Nov;76(11):1906-1910. doi: 10.1136/annrheumdis-2017-211284. Epub 2017 Jul 21.

PMID:
28733473
6.

Development of a feasible and responsive ultrasound inflammation score for rheumatoid arthritis through a data-driven approach.

Aga AB, Berner Hammer H, Christoffer Olsen I, Uhlig T, Kvien TK, van der Heijde D, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E, Høili C, Stray H, Noraas AL, Widding Hansen IJ, Bakland G, Lillegraven S, Lie E, Haavardsholm EA.

RMD Open. 2016 Dec 16;2(2):e000325. doi: 10.1136/rmdopen-2016-000325. eCollection 2016.

7.

Discordance between tender and swollen joint count as well as patient's and evaluator's global assessment may reduce likelihood of remission in patients with rheumatoid arthritis and psoriatic arthritis: data from the prospective multicentre NOR-DMARD study.

Michelsen B, Kristianslund EK, Hammer HB, Fagerli KM, Lie E, Wierød A, Kalstad S, Rødevand E, Krøll F, Haugeberg G, Kvien TK.

Ann Rheum Dis. 2017 Apr;76(4):708-711. doi: 10.1136/annrheumdis-2016-210283. Epub 2016 Oct 4.

PMID:
27707730
8.

Ultrasound in management of rheumatoid arthritis: ARCTIC randomised controlled strategy trial.

Haavardsholm EA, Aga AB, Olsen IC, Lillegraven S, Hammer HB, Uhlig T, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E, Høili C, Stray H, Noraas A, Hansen IJ, Bakland G, Nordberg LB, van der Heijde D, Kvien TK.

BMJ. 2016 Aug 16;354:i4205. doi: 10.1136/bmj.i4205.

9.

Achievement of Remission and Low Disease Activity Definitions in Patients with Rheumatoid Arthritis in Clinical Practice: Results from the NOR-DMARD Study.

Uhlig T, Lie E, Norvang V, Lexberg ÅS, Rødevand E, Krøll F, Kalstad S, Olsen IC, Kvien TK.

J Rheumatol. 2016 Apr;43(4):716-23. doi: 10.3899/jrheum.151132. Epub 2016 Feb 15.

PMID:
26879358
10.

First step in the development of an ultrasound joint inflammation score for rheumatoid arthritis using a data-driven approach.

Aga AB, Hammer HB, Olsen IC, Uhlig T, Kvien TK, van der Heijde D, Fremstad H, Madland TM, Lexberg ÅS, Haukeland H, Rødevand E, Høili C, Stray H, Bendvold AN, Soldal DM, Bakland G, Lie E, Haavardsholm EA.

Ann Rheum Dis. 2016 Aug;75(8):1444-51. doi: 10.1136/annrheumdis-2015-207572. Epub 2015 Jun 17.

PMID:
26085490
11.

First-time prescriptions of biological disease-modifying antirheumatic drugs in rheumatoid arthritis, psoriatic arthritis and axial spondyloarthritis 2002-2011: data from the NOR-DMARD register.

Lie E, Fagerli KM, Mikkelsen K, Rødevand E, Lexberg A, Kalstad S, Uhlig T, Kvien TK.

Ann Rheum Dis. 2014 Oct;73(10):1905-6. doi: 10.1136/annrheumdis-2014-205490. Epub 2014 Jul 2. No abstract available.

PMID:
24989896
12.

Is there a role for sulphasalazine in axial spondyloarthritis in the era of TNF inhibition? Data from the NOR-DMARD longitudinal observational study.

Fagerli KM, van der Heijde D, Heiberg MS, Wierød A, Kalstad S, Rødevand E, Mikkelsen K, Kvien TK, Lie E.

Rheumatology (Oxford). 2014 Jun;53(6):1087-94.

PMID:
24501243
13.

Time trends in disease activity, response and remission rates in rheumatoid arthritis during the past decade: results from the NOR-DMARD study 2000-2010.

Aga AB, Lie E, Uhlig T, Olsen IC, Wierød A, Kalstad S, Rødevand E, Mikkelsen K, Kvien TK, Haavardsholm EA.

Ann Rheum Dis. 2015 Feb;74(2):381-8. doi: 10.1136/annrheumdis-2013-204020. Epub 2013 Nov 27.

PMID:
24285493
14.

Switching between TNF inhibitors in psoriatic arthritis: data from the NOR-DMARD study.

Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kalstad S, Rødevand E, Mikkelsen K, Lexberg AS, Kvien TK.

Ann Rheum Dis. 2013 Nov;72(11):1840-4. doi: 10.1136/annrheumdis-2012-203018. Epub 2013 Apr 5.

PMID:
23562987
15.

Patient satisfaction with nursing consultations in a rheumatology outpatient clinic: a 21-month randomised controlled trial in patients with inflammatory arthritides.

Koksvik HS, Hagen KB, Rødevand E, Mowinckel P, Kvien TK, Zangi HA.

Ann Rheum Dis. 2013 Jun;72(6):836-43. doi: 10.1136/annrheumdis-2012-202296. Epub 2013 Feb 7.

PMID:
23393144
16.

The role of methotrexate co-medication in TNF-inhibitor treatment in patients with psoriatic arthritis: results from 440 patients included in the NOR-DMARD study.

Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Lexberg AS, Rødevand E, Kalstad S, Mikkelsen K, Kvien TK.

Ann Rheum Dis. 2014 Jan;73(1):132-7. doi: 10.1136/annrheumdis-2012-202347. Epub 2013 Jan 3.

PMID:
23291385
17.

Selecting patients with ankylosing spondylitis for TNF inhibitor therapy: comparison of ASDAS and BASDAI eligibility criteria.

Fagerli KM, Lie E, van der Heijde D, Heiberg MS, Kaufmann C, Rødevand E, Mikkelsen K, Kalstad S, Kvien TK.

Rheumatology (Oxford). 2012 Aug;51(8):1479-83. doi: 10.1093/rheumatology/kes057. Epub 2012 Apr 11.

PMID:
22499062
18.

Effectiveness of sulfasalazine and methotrexate in 1102 DMARD-naive patients with early RA.

Lie E, Uhlig T, van der Heijde D, Rødevand E, Kalstad S, Kaufmann C, Mikkelsen K, Kvien TK.

Rheumatology (Oxford). 2012 Apr;51(4):670-8. doi: 10.1093/rheumatology/ker356. Epub 2011 Dec 9.

PMID:
22157597
19.

Treatment strategies in patients with rheumatoid arthritis for whom methotrexate monotherapy has failed: data from the NOR-DMARD register.

Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Kalstad S, Kaufmann C, Rødevand E, Kvien TK.

Ann Rheum Dis. 2011 Dec;70(12):2103-10. doi: 10.1136/ard.2011.152363. Epub 2011 Aug 28.

PMID:
21875874
20.

[Effective treatment of rare diagnosis].

Rødevand E.

Tidsskr Nor Laegeforen. 2011 Jan 21;131(2):137. doi: 10.4045/tidsskr.10.1285. Norwegian. No abstract available.

21.

Effectiveness of switching between TNF inhibitors in ankylosing spondylitis: data from the NOR-DMARD register.

Lie E, van der Heijde D, Uhlig T, Mikkelsen K, Rødevand E, Koldingsnes W, Kaufmann C, Kvien TK.

Ann Rheum Dis. 2011 Jan;70(1):157-63. doi: 10.1136/ard.2010.131797. Epub 2010 Nov 9.

PMID:
21062852
22.

Paid work is associated with improved health-related quality of life in patients with rheumatoid arthritis.

Grønning K, Rødevand E, Steinsbekk A.

Clin Rheumatol. 2010 Nov;29(11):1317-22. doi: 10.1007/s10067-010-1534-z. Epub 2010 Jul 20.

23.

[Patient understanding important for the choice of names].

Rødevand E.

Tidsskr Nor Laegeforen. 2010 Mar 11;130(5):472. doi: 10.4045/tidsskr.10.0073. Norwegian. No abstract available.

24.

Effectiveness of adalimumab in treating patients with active psoriatic arthritis and predictors of good clinical responses for arthritis, skin and nail lesions.

Van den Bosch F, Manger B, Goupille P, McHugh N, Rødevand E, Holck P, van Vollenhoven RF, Leirisalo-Repo M, Fitzgerald O, Kron M, Frank M, Kary S, Kupper H.

Ann Rheum Dis. 2010 Feb;69(2):394-9. doi: 10.1136/ard.2009.111856. Epub 2009 Oct 7.

25.

Effectiveness and retention rates of methotrexate in psoriatic arthritis in comparison with methotrexate-treated patients with rheumatoid arthritis.

Lie E, van der Heijde D, Uhlig T, Heiberg MS, Koldingsnes W, Rødevand E, Kaufmann C, Mikkelsen K, Kvien TK.

Ann Rheum Dis. 2010 Apr;69(4):671-6. doi: 10.1136/ard.2009.113308. Epub 2009 Sep 9.

PMID:
19740904
26.

Contemporary use of disease-modifying drugs in the management of patients with early rheumatoid arthritis in Norway.

Nikolaisen C, Kvien TK, Mikkelsen K, Kaufmann C, Rødevand E, Nossent JC.

Scand J Rheumatol. 2009;38(4):240-5. doi: 10.1080/03009740802609566.

PMID:
19229766
27.

A novel mutation in the NOD2 gene associated with Blau syndrome: a Norwegian family with four affected members.

Milman N, Ursin K, Rødevand E, Nielsen FC, Hansen TV.

Scand J Rheumatol. 2009 May-Jun;38(3):190-7. doi: 10.1080/03009740802464194.

PMID:
19169908
28.

Comparison of work disability and health-related quality of life between males and females with rheumatoid arthritis below the age of 45 years.

Wallenius M, Skomsvoll JF, Koldingsnes W, Rødevand E, Mikkelsen K, Kaufmann C, Kvien TK.

Scand J Rheumatol. 2009 May-Jun;38(3):178-83. doi: 10.1080/03009740802400594.

PMID:
18991183
29.

[A previously healthy male with progressive high fever episodes].

Moser KH, Rødevand E, Hammerstrøm J, Steinum HO, Hannula R.

Tidsskr Nor Laegeforen. 2008 Aug 28;128(16):1845-7. Norwegian. No abstract available.

PMID:
18798351
30.

Adalimumab effectively reduces the rate of anterior uveitis flares in patients with active ankylosing spondylitis: results of a prospective open-label study.

Rudwaleit M, Rødevand E, Holck P, Vanhoof J, Kron M, Kary S, Kupper H.

Ann Rheum Dis. 2009 May;68(5):696-701. doi: 10.1136/ard.2008.092585. Epub 2008 Jul 28.

31.

Work disability and health-related quality of life in males and females with psoriatic arthritis.

Wallenius M, Skomsvoll JF, Koldingsnes W, Rødevand E, Mikkelsen K, Kaufmann C, Kvien TK.

Ann Rheum Dis. 2009 May;68(5):685-9. doi: 10.1136/ard.2008.092049. Epub 2008 May 29.

PMID:
18511544
32.
33.

[Systemic lupus erythematosus and pregnancy].

Skomsvoll JF, Aasarød K, Salvesen KA, Hoff M, Wallenius M, Rødevand E, Koksvik HS, Gilboe IM, Nossent HC.

Tidsskr Nor Laegeforen. 2007 Mar 15;127(6):725-9. Review. Norwegian.

34.

Drug insight: Anti-tumor necrosis factor therapy for inflammatory arthropathies during reproduction, pregnancy and lactation.

Skomsvoll JF, Wallenius M, Koksvik HS, Rødevand E, Salvesen KA, Spigset O, Kvien TK.

Nat Clin Pract Rheumatol. 2007 Mar;3(3):156-64. Review.

PMID:
17334338
35.

The comparative effectiveness of anti-TNF therapy and methotrexate in patients with psoriatic arthritis: 6 month results from a longitudinal, observational, multicentre study.

Heiberg MS, Kaufmann C, Rødevand E, Mikkelsen K, Koldingsnes W, Mowinckel P, Kvien TK.

Ann Rheum Dis. 2007 Aug;66(8):1038-42. Epub 2007 Jan 9.

36.

Adalimumab and methotrexate is more effective than adalimumab alone in patients with established rheumatoid arthritis: results from a 6-month longitudinal, observational, multicentre study.

Heiberg MS, Rødevand E, Mikkelsen K, Kaufmann C, Didriksen A, Mowinckel P, Kvien TK.

Ann Rheum Dis. 2006 Oct;65(10):1379-83. Epub 2006 May 5.

37.

A Norwegian DMARD register: prescriptions of DMARDs and biological agents to patients with inflammatory rheumatic diseases.

Kvien TK, Heiberg, Lie E, Kaufmann C, Mikkelsen K, Nordvåg BY, Rødevand E.

Clin Exp Rheumatol. 2005 Sep-Oct;23(5 Suppl 39):S188-94.

PMID:
16273806
38.
39.

[Clinical experience with TNF-alpha inhibitors in rheumatoid arthritis].

Wallenius M, Rødevand E, Skomsvoll JF.

Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1664-6. Norwegian.

40.

[Medical prophylaxis and treatment of steroid induced osteoporosis].

Rødevand E, Mikkelsen K, Nordvåg BY, Haga HJ, Førre Ø, Johnsen V, Kvien TK.

Tidsskr Nor Laegeforen. 2005 Jun 16;125(12):1643-5. Review. Norwegian.

41.

[Reversible infertility from nonsteroidal anti-inflammatory drugs].

Skomsvoll JF, Rødevand E, Koksvik HS, Salvesen KA, von Düring V, Rygnestad T, Østensen M.

Tidsskr Nor Laegeforen. 2005 Jun 2;125(11):1476-8. Review. Norwegian.

42.

Development of multiple malignancies after immunosuppression in a patient with Wegener's granulomatosis.

Hoff M, Rødevand E.

Rheumatol Int. 2005 Apr;25(3):238-40. Epub 2005 Jan 20.

PMID:
15660233
43.

[Side effects off allopurinol].

Rødevand E, Sletvold O, Kvande KT.

Tidsskr Nor Laegeforen. 2004 Oct 21;124(20):2618-9. Norwegian.

44.

[Medical certificates issued to help the patient].

Rødevand E.

Tidsskr Nor Laegeforen. 2004 Apr 1;124(7):984; author reply 984-5. Norwegian. No abstract available.

45.

[Combination therapy in rheumatoid arthritis].

Johnsen V, Førre Ø, Haga HJ, Kvien TK, Mikkelsen K, Nordvåg BY, Rødevand E.

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1511-3. Review. Norwegian.

PMID:
12822010
46.

[Training effects on pain in rheumatoid arthritis].

Jemtland Enger K, Bjørnstad K, Rødevand E, Skomsvoll JF.

Tidsskr Nor Laegeforen. 2003 May 29;123(11):1508-10. Review. Norwegian.

PMID:
12822009
47.

[Can specialist health care be used in a better way?].

Rødevand E.

Tidsskr Nor Laegeforen. 2002 Nov 10;122(27):2654-5. Norwegian. No abstract available.

48.

[Leflunomide--a new disease modifying anti-rheumatic agent].

Rødevand E, Kvien TK, Johnsen V.

Tidsskr Nor Laegeforen. 2001 Nov 10;121(27):3181-4. Review. Norwegian.

PMID:
11876141
49.

[Takayasu's arteritis].

Rødevand E, Skomsvoll JF, Wallenius M, Henriksen AZ, Skjaerpe T, Tafjord AB.

Tidsskr Nor Laegeforen. 2001 Jan 20;121(2):173-6. Norwegian.

PMID:
11475193
50.

Anti-cardiolipin autoantbodies and pulmonary embolism.

Rødevand E.

Scand J Rheumatol. 2001;30(3):178-9. No abstract available.

PMID:
11469533

Supplemental Content

Loading ...
Support Center